Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2203507 | 0.78 | KDM4E (0.33) | SLC2A1KDM4EMAPTESR2 | |
| SCHEMBL2203375 | 0.77 | KDM4E (0.34) | SLC2A1KDM4EMAPTESR2 | |
| SCHEMBL2203504 | 0.64 | ALDH1A1 (0.39) | MAPT | |
| SCHEMBL19465403 | 0.61 | SLC2A1 (0.55) | SLC2A1KCNH2 | |
| SCHEMBL27287382 | 0.60 | KCNH2 (0.58) | SLC2A1KCNH2 | |
| SCHEMBL4990564 | 0.60 | SLC2A1 (0.60) | SLC2A1 | |
| SCHEMBL3124987 | 0.60 | SLC2A1 (0.60) | SLC2A1 | |
| SCHEMBL10589876 | 0.60 | SLC2A1 (0.60) | SLC2A1 | |
| SCHEMBL4071245 | 0.60 | SLC2A1 (0.60) | SLC2A1 | |
| SCHEMBL8785774 | 0.60 | SLC2A1 (0.60) | SLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977512-B2 | Amine derivative, and production method and use thereof | KUREHA CORPORATION (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20080293951-A1 | Amin Derivative, and Production Method and Use Thereof | KUREHA CORPORATION | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293951-A1 | Amin Derivative, and Production Method and Use Thereof | BCAT2, BCAT1, MRPL9 | SLC2A1 4155/4885KCNH2 1856/4885KDM4E 1006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.